BOSTON SCIENTIFIC CORPORATION XENFORM; MESH, SURGICAL, NON-SYNTHETIC, UROGYNECOLOGIC FOR APICAL VAGINAL AND UTERINE PRO
|
Back to Search Results |
|
Model Number M0068302450 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Unspecified Infection (1930); Pain (1994); Urinary Retention (2119); Abnormal Vaginal Discharge (2123); Discomfort (2330); Obstruction/Occlusion (2422); Constipation (3274)
|
Event Date 03/09/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(6).(b)(4).Study name: (b)(6).The complaint device is not expected to be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|
|
Event Description
|
It was reported to boston scientific corporation that a xenform device was implanted during a pelvic floor repair procedure with xenform including vaginal-approach hysteropexy procedure performed on (b)(6) 2016.According to the complainant, on (b)(6) 2016, the patient presented with bladder outlet obstruction and was admitted to the hospital on (b)(6) 2016.She underwent a revision prolapse surgery and the device was completely removed from the posterior vaginal wall.She was then discharged on (b)(6) 2016 and the event of obstruction resolved on (b)(6) 2016.
|
|
Event Description
|
It was reported to boston scientific corporation that a xenform device was implanted during a pelvic floor repair procedure with xenform including vaginal-approach hysteropexy procedure performed on (b)(6) 2016.According to the complainant, on (b)(6) 2016, the patient presented with bladder outlet obstruction and was admitted to the hospital on (b)(6) 2016.She underwent a revision prolapse surgery and the device was completely removed from the posterior vaginal wall.She was then discharged on (b)(6) 2016 and the event of obstruction resolved on (b)(6) 2016.Additional information received on november 30, 2018.On (b)(6) 2016, aside from bladder outlet obstruction, the patient also experienced fecal impaction, wound infection in the posterior compartment with symptoms of difficulty voiding, increased vaginal pain, malaise, and vaginal drainage.The patient reportedly had tried multiple stool softeners and enemas and was able to have a bowel movement.On (b)(6) 2016, the patient was admitted to the hospital and underwent an inpatient surgical intervention including transurethral mobilization of sling, and complete explant of the study device from the posterior vaginal wall.The patient was then discharged from the hospital on (b)(6) 2016.She was also treated with iv antibiotics for the wound infection.All events were resolved on (b)(6) 2016.The investigator assessed the wound infection and fecal impaction events as moderate in severity and pelvic floor related.The assessment of the relationship of this to the procedure and/or device has not yet been provided.
|
|
Manufacturer Narrative
|
Patient id: (b)(6).Study name: (b)(4).
|
|
Manufacturer Narrative
|
Patient id:(b)(6) the following problem codes capture the following reportable events: 2422 - obstruction.2119 - urinary retention.1930 - infection.1994 - pain.Study name: (b)(6) xenform a/a postmarket.Conclusion code 4316 is being used in lieu of an adequate conclusion code for device not returned.The complaint device is not expected to be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Updated.
|
|
Event Description
|
It was reported to boston scientific corporation that a xenform device was implanted during a pelvic floor repair procedure with xenform including vaginal-approach hysteropexy procedure performed on (b)(6) 2016.According to the complainant, on (b)(6) 2016, the patient presented with bladder outlet obstruction and was admitted to the hospital on (b)(6) 2016.She underwent a revision prolapse surgery and the device was completely removed from the posterior vaginal wall.She was then discharged on (b)(6) 2016 and the event of obstruction resolved on (b)(6) 2016.On (b)(6) 2016, aside from bladder outlet obstruction, the patient also experienced fecal impaction, wound infection in the posterior compartment with symptoms of difficulty voiding, increased vaginal pain, malaise, and vaginal drainage.The patient reportedly had tried multiple stool softeners and enemas and was able to have a bowel movement.On (b)(6) 2016, the patient was admitted to the hospital and underwent an inpatient surgical intervention including transurethral mobilization of sling, and complete explant of the study device from the posterior vaginal wall.The patient was then discharged from the hospital on (b)(6) 2016.She was also treated with iv antibiotics for the wound infection.All events were resolved on (b)(6) 2016.The investigator assessed the wound infection and fecal impaction events as moderate in severity and pelvic floor related.The assessment of the relationship of this to the procedure and/or device has not yet been provided.The events of wound infection and fecal impaction have been assessed by the investigator as definitely related to the procedure, and definitely related to the device.For the event of wound infection, it was determined to be in the area of the suture line, less than or equal to 1cm, and associated with spontaneous pain.
|
|
Search Alerts/Recalls
|
|
|